Wrapmanager Inc Bicycle Therapeutics PLC Transaction History

Wrapmanager Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$12.95 - $46.99 $114,413 - $415,156	-8,835 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$40.12 - $59.5 $9,267 - $13,744	-231 Reduced 2.55%	8,835 $388,000
Q4 2021 Feb 07, 2022	SELL	$41.7 - $61.14 $23,101 - $33,871	-554 Reduced 5.76%	9,066 $552,000
Q3 2021 Nov 10, 2021	SELL	$27.95 - $44.24 $1,285 - $2,035	-46 Reduced 0.48%	9,620 $400,000
Q2 2021 Aug 04, 2021	BUY	$27.0 - $32.28 $260,982 - $312,018	9,666 New	9,666 $293,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $431M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

Stay updated on Wrapmanager Inc with notifications on news.